← back to search

Catherine Lee

Acadia Pharmaceuticals (United States) · US
Area of research
Physiology · Oncology
Research interest
Research interests include Nutrition and Health in Aging, Cancer Risks and Factors, Radiation Therapy and Dosimetry, and Effects of Radiation Exposure.
h-index
41
citations
6,855
works
390
NIH funding
primary concept
Medicine
email

Recent publications

Impact of Delayed HIV Diagnosis and Treatment on Dementia Risk in Later Life.
2026cited by 0position: contributordoi
Differences in breast cancer survival across Asian American ethnicities compared with non-Latina White females in Kaiser Permanente Northern California.
2026cited by 0position: contributordoi
Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation
JAMA 2025cited by 13position: middledoi
The association of bone density and hip fracture risk among Asian women
Osteoporosis International 2025cited by 6position: lastdoi
Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN).
2025cited by 3position: contributordoi
Heterogeneity in BMI Percentile and Weight Status Among Asian American Youth.
2025cited by 1position: contributordoi
Association of intravenous ketamine with change in depressive symptoms in a large integrated health care system.
2025cited by 0position: contributordoi
Estimating weighted quantile treatment effects with missing outcome data by double sampling.
2025cited by 0position: contributordoi
Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed With Diabetic Polyneuropathy: Retrospective Cohort Study.
2025cited by 0position: contributordoi
Supplementary Table 2 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025cited by 0position: contributordoi
Supplementary Table 1 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025cited by 0position: contributordoi
Supplementary Table 3 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025cited by 0position: contributordoi
Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025cited by 0position: contributordoi
Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025cited by 0position: contributordoi
Supplementary Table 6 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025cited by 0position: contributordoi
Hypertension, Cardiovascular Risk Factors, and Uterine Fibroid Diagnosis in Midlife
JAMA Network Open 2024cited by 16position: middledoi
Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN)
The Journal of Clinical Endocrinology & Metabolism 2024cited by 10position: middledoi
Risk of Infection in Older Adults With Type 2 Diabetes With Relaxed Glycemic Control.
2024cited by 3position: contributordoi
Alanine aminotransferase elevation varies by ethnicity among Asian and Pacific Islander children with overweight or obesity.
2024cited by 2position: contributordoi
Predictors of Long-Acting Injectable Antipsychotic Medication Use in Patients with Schizophrenia Spectrum, Bipolar, and Other Psychotic Disorders in a US Community-based, Integrated Health System.
2024cited by 1position: contributordoi
A protocol for remote collection of skeletal muscle mass via D3-creatine dilution in community-dwelling postmenopausal women from the Women's Health Initiative.
2024cited by 0position: contributordoi
The Effect of City-Level Sugar-Sweetened Beverage Taxes on Longitudinal HbA1c and Incident Diabetes in Adults With Prediabetes.
2024cited by 0position: contributordoi
Supplementary Table 1 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi
Data from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi
Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi
Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi
Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi
Supplementary Table 2 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi
Supplementary Table 3 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi
Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 78 papers (2019–2026)Bette J. Caan · Indiana University School of Medicine48 papers (2019–2025)Elizabeth M Cespedes Feliciano · Colorado Permanente Medical Group48 papers (2021–2025)Marc K. Hellerstein · University of California, Berkeley47 papers (2023–2025)Kathryn H. Schmitz · UPMC Hillman Cancer Center47 papers (2023–2025)William J. Evans · Oregon Health & Science University47 papers (2023–2025) · 47 papers (2023–2025)En Cheng · Montefiore Einstein Comprehensive Cancer Center47 papers (2023–2025)Jeffrey A Meyerhardt · Broad Institute47 papers (2023–2025)Kristin L. Campbell · RTI Health Solutions47 papers (2023–2025) · 47 papers (2023–2025) · 47 papers (2023–2025) · 47 papers (2023–2025)Alexandra M Binder · UCLA Health47 papers (2023–2025)Peggy M Cawthon · Pacific Medical (China)47 papers (2023–2025)Gabriel J. Escobar · Kaiser Permanente5 papers (2018–2025)Lawrence H. Kushi · Kaiser Permanente Walnut Creek Medical Center5 papers (2020–2026)Carlos Iribarren · University of Washington4 papers (2021–2022)Nareg Roubinian · California Northstate University4 papers (2019–2023)Michael J. Silverberg · Kaiser Permanente3 papers (2020–2026)